Related Experiment Video

Updated: May 2, 2026

RhoC GTPase Activation Assay
09:58

RhoC GTPase Activation Assay

Published on: August 22, 2010

12.2K

HMG-CoA reductase regulates CCL17-induced colon cancer cell migration via geranylgeranylation and RhoA activation

Amr A Al-Haidari1, Ingvar Syk1, Henrik Thorlacius1

  • 1Department of Clinical Sciences, Section of Surgery, Skåne University Hospital, Lund University, Malmö, Sweden.

Biochemical and Biophysical Research Communications
|March 4, 2014
PubMed
Abstract

Insights

Simvastatin, a cholesterol-lowering drug, was found to inhibit colon cancer cell migration by affecting RhoA activation. This suggests statins could be potential tools against colon cancer metastasis.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Simvastatin is a widely used cholesterol-lowering drug.
  • Emerging evidence indicates statins possess anti-tumoral properties.
  • The specific anti-cancer mechanisms of simvastatin require further elucidation.

Purpose of the Study:

  • To investigate the effect of simvastatin on colon cancer cell migration.
  • To explore the underlying molecular mechanisms of simvastatin's action on colon cancer cells.

Main Methods:

  • Colon cancer cell migration was assessed using chemotaxis assays.
  • In vitro proliferation and apoptosis were evaluated.
  • Active RhoA protein levels were quantified using G-LISA assays.

Main Results:

  • Simvastatin dose-dependently inhibited CCL17-induced colon cancer cell migration.
  • Simvastatin did not affect colon cancer cell proliferation or apoptosis.
  • Simvastatin reduced CCL17-induced RhoA activation, an effect reversed by mevalonate and geranylgeranyl pyrophosphate (GGPP).

Conclusions:

  • HMG-CoA reductase inhibition by simvastatin regulates colon cancer cell migration via geranylgeranylation and RhoA activation.
  • Simvastatin may serve as a therapeutic agent to impede CCL17-dependent colon cancer cell migration and metastasis.
Keywords:
ChemokinesColonMetastasisMigrationSimvastatin

More Related Videos

A Flow Cytometry-based Assay to Identify Compounds That Disrupt Binding of Fluorescently-labeled CXC Chemokine Ligand 12 to CXC Chemokine Receptor 406:56

A Flow Cytometry-based Assay to Identify Compounds That Disrupt Binding of Fluorescently-labeled CXC Chemokine Ligand 12 to CXC Chemokine Receptor 4

Published on: March 10, 2018

13.4K
A Kinetic Fluorescence-based Ca2+ Mobilization Assay to Identify G Protein-coupled Receptor Agonists, Antagonists, and Allosteric Modulators07:41

A Kinetic Fluorescence-based Ca2+ Mobilization Assay to Identify G Protein-coupled Receptor Agonists, Antagonists, and Allosteric Modulators

Published on: February 20, 2018

8.4K

Related Concept Videos

Cell Polarization by Rho Proteins01:21

Cell Polarization by Rho Proteins

Cell polarity is the asymmetric distribution of cellular and membrane components, making one side of the cell different from the other. This polarity is essential to many processes such as embryogenesis, axon migration, glucose transport across epithelial cells, and directional cell migration. A migrating cell responds to intracellular or extracellular signals via molecular cascades that reorganize the actin cytoskeleton to establish this polarity. In these cells, the Rho family proteins Cdc42,...
3.2K
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
4.4K
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
5.7K
Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
2.5K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.0K
Chemotaxis and Direction of Cell Migration01:21

Chemotaxis and Direction of Cell Migration

Cells can detect chemical cues in their environment and reorganize the cytoskeleton to migrate toward them or away from them. This directional migration, called chemotaxis, is essential during embryogenesis and development, immune response, tissue repair and regeneration, and reproduction. These chemical cues can either attract or repel the cell's movement. For example, axon development is determined by a combination of chemoattractants and chemorepellents that direct the growing axon...
5.0K